IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,547,807 | +12.1% | 126,162 | +29.5% | 0.00% | 0.0% |
| Q2 2023 | $5,841,242 | +20165.2% | 97,419 | +16609.9% | 0.00% | – |
| Q1 2023 | $28,824 | -13.1% | 583 | +0.3% | 0.00% | – |
| Q4 2022 | $33,157 | -39.7% | 581 | -50.5% | 0.00% | – |
| Q3 2022 | $55,000 | -47.6% | 1,173 | -58.3% | 0.00% | – |
| Q2 2022 | $105,000 | -48.5% | 2,813 | -58.8% | 0.00% | – |
| Q1 2022 | $204,000 | +68.6% | 6,832 | +92.0% | 0.00% | – |
| Q4 2021 | $121,000 | +44.0% | 3,558 | +57.9% | 0.00% | – |
| Q3 2021 | $84,000 | +1300.0% | 2,253 | +1453.8% | 0.00% | – |
| Q2 2021 | $6,000 | +50.0% | 145 | +45.0% | 0.00% | – |
| Q1 2021 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |